Alzheimer’s Study – RefocusALZ

If you or a loved one has been diagnosed with Alzheimer’s disease, or a physician suspects it may be Alzheimer’s disease, you or they may be eligible to participate in a clinical research study. RefocusALZ is a new clinical trial for Alzheimer’s disease. The purpose of this trial is to determine if a new, twice-a-day, oral drug candidate called simufilam is safe and effective in slowing down the progression of mild-to-moderate Alzheimer’s disease. Simufilam is an investigational drug candidate that has not been approved by the US Food and Drug Association (FDA), or any regulatory agency, for the treatment of any condition.

To be considered for the RefocusALZ study, patients must:

  • Ages 50 to 87 years old
  • Be diagnosed with, or have a suspected clinical diagnosis of, Alzheimer’s Disease
  • Have a gradual change in memory for six months or more
  • Have a family member or loved one who can be available as a study partner during the entire study
  • Be fully vaccinated for COVID-19 or have had a previous COVID-19 infection

Other criteria will apply. There is no cost to the patient to participate in the RefocusALZ trial or for any of the study-related procedures. No hospitalization is required. You may be compensated for your time and travel for each clinical study appointment.


1 Step 1

Join The Study

No Insurance Required – No Cost to Patient

  • Qualified participants will receive investigational medication and study-related medical care at no cost
  • Participants may also receive compensation for time and travel
  • No health insurance required and no overnight stays
To learn more and see all active clinical research studies, please visit our Active Studies page or contact our Research Team.
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right

Clinical Study FAQs

  • Will I have to discontinue any current medicine?
  • Does participating in this study cost me anything?
  • Do I need health insurance to participate?
  • Are there any risks to participating in this study?
  • What are the potential benefits of participating?
Will I have to discontinue any current medicine?

Do not discontinue any medicine unless you are advised to do so by the study center staff or your primary care physician.

Does participating in this study cost me anything?

There is no cost to you or your insurance provider for participating in this study. If you qualify for this study, study-related care may be provided at no cost to you.

Do I need health insurance to participate?

No, health insurance is not required in order to participate.

Are there any risks to participating in this study?

There may be potential risks to participating in this study. All drugs and medical procedures carry a risk of side effects; therefore, it is possible that participants may experience some discomfort or other reactions from use of the study drug. If you decide to participate, the study staff will explain the potential risks to you before any study procedures are conducted.

What are the potential benefits of participating?

Participants may or may not receive any benefit from being in this study. It is possible that participants may get better, stay the same, or get worse. In the future, other people with mild cognitive impairment or mild dementia associated with Parkinson’s disease or prodromal or manifest Lewy body dementia may be helped by this research.


This website is for informational purposes only. Please dial 911 for emergency.

Parkinson's Tempo 3 Study
This is default text for notification bar